Henry Ji brings 25+ years of experience in the biotechnology and life sciences industry. Dr. Ji has been Chairman of Scilex Holding from March 2019 to present and served as the CEO...
Suketu D. Desai, Ph.D. has 25+ years of experience in the Biologics and Pharmaceutical Industry. Suketu is Chief Technical Officer and Senior Vice President, Chemistry, Manufacturing and Controls, Regulatory CMC, and Quality...
Dmitri Lissin currently serves as Chief Medical Officer and Senior Vice President, Clinical Development and Medical Affairs of Scilex/Semnur Pharmaceuticals (2015 – present).
Prior to Semnur, from 2011-2015, Dmitri was Vice President of...
Mr. Khemani brings more than 25 years of global pharmaceutical experience to Scilex, an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute...
Steve Lincoln serves as General Counsel, Chief Compliance Officer for Scilex Holding Company. Steve has been involved in the biopharma industry for more than 21 years.
Most recently, he was Counsel to the...
Stephen Ma serves as the Chief Financial Officer and Senior Vice President since September 2023. Prior to that, Mr. Ma served as the Company’s Chief Accounting Officer and Vice President of Finance.
Mr....
Dr. Elaine Chan heads Medical Affairs at Scilex, since 2022. Prior to joining Scilex, Dr. Chan was Senior Director at Genentech Inc (a member of the Roche group), one of the world’s...
Gigi DeGuzman is a seasoned professional with over 25 years of experience in human resources, operations management, facilities management, event planning, executive coordination, and administrative operations. She has played a significant role...
Mike has over 25 years in the pharmaceutical industry. Mike currently serves as the National Sales Director at Scilex Holding Company. Mike joined Scilex in 2018 as a Regional Business Director to...
Sumant Rajendran heads up the Marketing department and brings over 20 years’ experience to Scilex. He has been at the company since mid-2019 and has overseen the growth of our marketed portfolio...